Rat IgG2a kappa Isotype Control (eBR2a), eBioscience

The University of Virginia has awarded contract A207_PO-0445843-V3 to Life Technologies Corporation effective July 11, 2026, with a cumulative contract value of $88. The contract covers the procurement of Rat Immunoglobulin G, Subclass 2a, kappa Isotype Control (eBR2a) manufactured by eBioscience. The line item specifies a quantity of 88 units at a unit price of $1 per unit, with delivery to the buyer.

This purchase order represents a research-grade biological reagent acquisition by the University of Virginia through Life Technologies Corporation as the prime contractor. The relatively modest contract value and specific nature of the isotype control product indicate this is a routine procurement of laboratory materials for use in immunological research or diagnostics applications at the Virginia-based institution. No specific period of performance or alternative places of performance are identified in the contract documentation provided.